Navigation Links
ADVENTRX Pharmaceuticals Provides Update on ANX-514
Date:2/15/2011

may fail to perform as expected; ADVENTRX's current dependence on the success of Exelbine and ANX-514 and the possibility that ADVENTRX does not receive regulatory approval of Exelbine or ANX-514 on a timely basis, or at all; the risk that ADVENTRX may not be able to successfully commercialize Exelbine or ANX-514 if it receives regulatory approval for those product candidates; the risk that ADVENTRX will pursue development activities at levels on timelines, or will incur unexpected expenses, that shorten the period through which its operating funds will sustain it; the potential that Exelbine and/or ANX-514 will be subject to a future collaboration or other strategic transaction; the risk that ADVENTRX's acquisition of SynthRx, Inc. may not be consummated; the potential for ADVENTRX to enter into a merger or other business combination in connection with a new product candidate acquisition resulting in a successor entity that focuses its resources on developing products and product candidates other than ADVENTRX's existing product candidates, including Exelbine and ANX-514; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov.

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
2. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
5. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
6. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
7. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
8. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
9. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
10. ADVENTRX Reports Third Quarter Financial Results
11. ADVENTRX to Present at the Wall Street Analyst Forum 21st Annual Institutional Investor Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... March 26, 2015 According to ... Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional ... Cancer, Bone Metastasis) - Global Forecasts to 2019", published ... reach around $462.0 Million growing at a CAGR of ... tables and 57 figures spread through 195 pages and ...
(Date:3/26/2015)... 2015 A new survey of health ... research (CER) will yield improvements in health care ... impact of CER in the current environment. The ... stakeholders shows that they view CER as important, ... care and decision-making in the next three to ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4
... Oct. 30 Volunteers who guide low-income,and minority ... (LPN), help them to overcome major obstacles that ... outcomes, according to a,study presented October 28, 2007, ... 49th Annual Meeting in Los Angeles. Minority ...
... 30 Leading researchers,will present 68 data ... alfa-2b) and REBETOL(R),(ribavirin, USP) combination therapy, a ... chronic hepatitis C, at the 58th American ... Annual Meeting in Boston, Nov. 2-6. ...
Cached Medicine Technology:Patient Navigators Help Minority, Low-Income Cancer Patients Get Life-Saving Treatments 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 7
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... 2015 “The SWEET Act is an important ... more available and help parents who are working to reduce ... reasonable approach to support public health, and we will continue ... the health of all families,” said Dr. Jane Delgado President ... the introduction of the Sugar-Sweetened Beverage Tax (SWEET) Act by ...
(Date:3/26/2015)... Frencisco, CA (PRWEB) March 26, 2015 ... Center are proud to announce expanded offerings for Bay ... San Francisco Dental Implant Center has long been a ... have expanded its offerings to meet the strong demand ... in our reputation as a top-rated dental implant facility ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... In the key developed markets, the hypertension market ... set to decrease through 2020 at a negative CAGR (0.9%) ... up to 2017 at a 2.6% CAGR and a decline ... the surging penetration of fixed-dose combination drugs like Azor, Amturnide, ... HCT, and Tekamlo), a hike in the prevalence population to ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... FRIDAY, July 8 (HealthDay News) -- Obese people who ... to suffer from complications than those of normal weight, ... are often used by insurance companies, the Johns Hopkins ... and hospitals are reimbursed for more complex procedures or ...
... As any student who,s had to study for multiple exams ... facts one after another is challenging. As you study for ... the history exam is forgotten. It,s been widely believed that ... have the capacity necessary to process both memories in quick ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... threatens America,s future reveals that obesity rates climbed over the ... reported a decline in the proportion of excessively overweight residents. ... 30 percent of the people in 12 states are obese. ...
... analysis of heart disease and stroke statistics collected in 192 ... relative burden of the two diseases varies widely from country ... to researchers at the University of California, San Francisco. ... UCSF scientists found that developing countries tend to suffer more ...
... at the Neglected Tropical Diseases Meeting of the International ... for Neglected Diseases initiative (DNDi) announced the first research ... portfolio to address unmet needs of patients in Africa ... potential of the drug flubendazole to treat a highly ...
... (HealthDay News) -- It is well-known that smoking is unhealthy, ... require total hip or knee replacement, according to a new ... doing vigorous physical activity increased the likelihood of joint replacement. ... of 11,388 men who were followed from 1996-1999 to March ...
Cached Medicine News:Health News:Obesity May Increase Risk of Surgical Complications 2Health News:Study demonstrates how memory can be preserved -- and forgetting prevented 2Health News:U.S. Obesity Epidemic Continues to Spread 2Health News:U.S. Obesity Epidemic Continues to Spread 3Health News:Heart disease and stroke worldwide tied to national income 2Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 2Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 3Health News:Men Who Smoke at Lower Risk of Joint Replacement: Study 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTN/1Q-CAB chairs are recommended for ... clean room, static control, health care ...
Medicine Products: